Asston Pharmaceuticals Complete Financial Statements
In FYNone, Asston Pharmaceuticals (APL) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of 15.4% and ROE of 36.4%. Full financial statements from FY2022 to FY2025 (4 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see APL stock price BSE.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
APL Revenue, Net Profit & EBITDA — Year-on-Year Growth
APL YoY (March 2025 vs Period) — revenue -100.0%, net profit -100.0%, EBITDA -100.0%, expenses -100.0%. See APL P/B ratio history to compare market price against book value per share.
APL Income Statement — Revenue, EBITDA & Net Profit
Asston Pharmaceuticals revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin 15.4%. Check Asston Pharmaceuticals market worth to track the company's total market size over time.
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 |
|---|---|---|---|---|---|
| Revenue | 0 | 26 | 16 | 7 | 11 |
| Expenses | 0 | 20 | 13 | 5 | 10 |
| EBITDA | 0 | 6 | 3 | 2 | 1 |
| Operating Profit Margin % | 0.00% | 22.00% | 16.00% | 23.00% | -4.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 1 | 1 | 1 | 0 |
| Profit Before Tax | 0 | 5 | 2 | 1 | 0 |
| Tax | 0 | 1 | 1 | 0 | 0 |
| Net Profit | 0 | 4 | 1 | 1 | 0 |
| Earnings Per Share (₹) | 0.00 | 6.14 | 2.37 | 1.89 | 11.62 |
APL Balance Sheet — Assets, Liabilities & Shareholders' Equity
APL total assets ₹28 Cr, total equity ₹11 Cr, total liabilities ₹ Cr (2025) — ROE 36.4%.
| Particulars | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| Total Assets | 28 | 20 | 14 | 10 |
| Current Assets | 27 | 18 | 11 | 7 |
| Fixed Assets | 1 | 1 | 1 | 1 |
| Capital Work in Progress | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 |
| Other Assets | 27 | 19 | 13 | 9 |
| LIABILITIES | ||||
| Total Liabilities | ||||
| Current Liabilities | 2 | 2 | 2 | 1 |
| Non-Current Liabilities | ||||
| SHAREHOLDERS' EQUITY | ||||
| Total Equity | 11 | 6 | 2 | 1 |
| Share Capital | 6 | 1 | 1 | 1 |
| Reserves & Surplus | 5 | 6 | 1 | 0 |
APL Cash Flow Statement — Operating, Investing & Financing
Asston Pharmaceuticals operating cash flow ₹0 Cr, investing ₹1 Cr, financing ₹-1 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 |
|---|---|---|---|---|
| Operating Activities | 0 | -4 | 0 | -1 |
| Investing Activities | 1 | 0 | -1 | 0 |
| Financing Activities | -1 | 4 | 1 | 1 |
| Net Cash Flow | 0 | 0 | 0 | 0 |